Table 2 Characteristics of the patients (Study 2: Olmesartan, 12 weeks)

From: Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension

 

Pretreatment

Posttreatment

n (M/F)

9 (4/5)

Age (years)

56.6±1.8

Body mass index (kg m−2)

25.0±0.4

24.4±0.7

Waist circumference (cm)

84.8±2.2

83.9±2.7

Systolic blood pressure (mm Hg)

162.9±4.3

141.7±6.8a

Diastolic blood pressure (mm Hg)

97.8±3.9

79.3±3.0a

Pulse rate (beats min−1)

74.0±3.7

71.6±3.7

Biochemical data

 Total cholesterol (mg dl−1)

196.4±9.5

208.3±11.3

 HDL cholesterol (mg dl−1)

50.7±3.5

52.4±4.0

 LDL cholesterol (mg dl−1)

128.1±8.5

132.8±10.7

 Triglycerides (mg dl−1)

82 (71–112)

97 (75–118)

 Glucose (mg dl−1)

97.9±2.3

98.0±2.3

 Insulin (μU ml−1)

4.9 (3.4–5.1)

5.0 (2.9–6.3)

 HOMA-R

1.11 (0.86–1.24)

1.17 (0.73–1.40)

  1. Abbreviations: F, female; HDL, high-density lipoprotein; HOMA-R, homeostasis model assessment ratio; LDL, low-density lipoprotein; M, male. Variables are expressed as n, means±s.e.m. or medians (interquartile ranges).
  2. aP<0.05 vs. pretreatment.
Back to article page